Bill Andrews | defytime

Defytime Announces Initial Coin Offering (ICO) Public Pre-Sale Start

We hereby have the pleasure to officially announce our Public ICO Plan, details below. Defytime will host a pre-sale ICO for friends and...

61 views

Detailed Structure of Telomerase - the enzyme that will battle Aging - revealed by Scientists

More than 30 years ago, when UC Berkeley researchers discovered, in an organism called Tetrahymena, Telomerase, the enzyme that lengthens...

24 views

New clinical study may be the World's first cure for Alzheimer's disease. Lead scientists be

ORLANDO, Fla., Jan. 10, 2018 /PRNewswire/ -- Libella Gene Therapeutics LLC will conduct an outside the United States(OUS) clinical trial...

55 views

Dr. Bill Andrews, PhD, interviewed on Stuff.co.nz by Lisa Tamati

As another year has just rolled over and I quickly approach the half century mark in my life, I have to admit to a growing desire to do...

23 views

Telomere Lengthening: Curing all diseases including cancer and aging

"Telomere Lengthening: Curing All Diseases Including Aging and Cancer" is Dr. Bill Andrews' follow-up to the 2014 release "Bill Andrews...

5 views

1

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Telomerase Gene Therapy treatment of age-related diseases and telomere syndromes does not favor canc

Gene therapy vectors carrying the telomerase gene do not increase the risk of cancer

Dr. Bill Andrews, Ph.D. explains Telomeres, Telomerase and Gene Therapy on CNN Turkey

Dr. Bill Andrews, Ph.D, explains the role of Telomeres and Telomerase in Aging on Korean National Te

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Rapidly Aging Cells May Contribute to Shorter Lifespan of Fabry Patients, Study Finds

Shorter Telomeres Increase Risk for MS Disability Progression